AAL vs CURI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 03, 2026

AAL

58.3
AI Score
VS
AAL Wins

CURI

45.9
AI Score

Investment Advisor Scores

AAL

58score
Recommendation
HOLD

CURI

46score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric AAL CURI Winner
Forward P/E 42.9185 13.459 CURI
PEG Ratio 0.7613 0 Tie
Revenue Growth 16.3% 22.3% CURI
Earnings Growth -88.2% 1400.0% CURI
Tradestie Score 58.3/100 45.9/100 AAL
Profit Margin -0.6% 0.0% CURI
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY CURI

Relative Price Performance (Last 90 Days)

AAL 1M: -18.1% · 3M: -2.7% CURI 1M: +1.1% · 3M: -2.3%

Current Technical Phase

AAL

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.5%), weak momentum, RSI 36

RSI (14): 36.0 · Price: $13.13

CURI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.9 · Price: $2.71

Fundamentals Snapshot

Metric AAL CURI
Market Cap
Forward P/E 5.7 8.7
Trailing P/E
Revenue (TTM)
Revenue Growth 0.2% 0.2%
Gross Margin 0.2% 0.6%
Operating Margin 0.0% 0.4%
EPS -0.50 -0.01
Dividend Yield 0.11%

Frequently Asked Questions

Based on our detailed analysis, AAL is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.